Dr Karin Schmitt

Karin is a globally experienced science and business executive with more than 25 years of diverse experience in biotech drug discovery, platform development and medical device companies. With a recent emphasis on cell and gene therapy, her career spans the Boston area, Silicon Valley and the Cambridge cluster. Karin has been an early employee in several successful start-ups, including Millennium Pharmaceuticals, Exelixis and Horizon Discovery making significant contributions to the rapid growth of these companies to IPO and beyond. Karin obtained her PhD in molecular biology at the University of Southern California in Los Angeles, followed by three years of post-doctoral research in genetics at the University of Cambridge.